Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
Crossref DOI link: https://doi.org/10.1186/s12888-016-0708-x
Published Online: 2016-01-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lachaine, Jean
Sikirica, Vanja
Mathurin, Karine